Summary

The global cold plasma market is projected to reach USD 3.03 billion by 2031 from USD 2.15 billion in 2026, at a CAGR of 7.1 % during the forecast period. The growing need for effective, low-temperature sterilization and surface modification of medical devices is driving the adoption of cold plasma technology. Cold plasma enables non-thermal treatment of heat-sensitive medical devices while reducing reliance on harsh chemicals and minimizing material damage. Increasing demand for sterile medical equipment, infection control, and advanced surface treatment, particularly for catheters, implants, surgical instruments, and other polymer-based devices, is expected to support market growth. Furthermore, rising healthcare expenditure, stringent sterilization requirements, and advancements in plasma-based medical technologies are likely to drive further adoption of cold plasma solutions. Based on industry, the medical industry segment of the cold plasma market is expected to register the highest share during the forecast period. The growing adoption of plasma-based solutions for wound healing, sterilization, disinfection, and surgical applications mainly drives the demand for cold plasma technology in the medical industry. The increasing prevalence of chronic wounds, rising demand for minimally invasive procedures, and growing emphasis on infection prevention are supporting the adoption of cold plasma systems across hospitals, clinics, and medical-device manufacturing facilities. Moreover, the focus on non-thermal sterilization, antimicrobial treatment, reduced chemical usage, patient safety, and environmentally friendly healthcare processes is encouraging the adoption of cold plasma technologies. Technological advancements in atmospheric-pressure plasma jets, plasma-based wound-care devices, and plasma sterilization systems are further expanding the scope of cold plasma applications, supporting the medical industry segment in registering the highest share during the forecast period. By application, the surface treatment & activation segment is expected to capture the highest CAGR of the cold plasma market. Based on application, the surface treatment & activation segment is anticipated to register the highest CAGR during the forecast period. This growth can be attributed to the increasing use of cold plasma to enhance surface adhesion, wettability, printability, and bonding properties across polymer & plastics, textiles, electronics, and automotive applications. The non-thermal, environmentally friendly nature of cold plasma, along with its ability to reduce reliance on chemical treatments, is driving its adoption across industries. Moreover, advancements in plasma technology, development of application-specific systems, and increasing demand for efficient and customizable surface treatment solutions are expected to further accelerate segment growth. By regime, the low-pressure cold plasma segment is expected to register the highest CAGR in the cold plasma market. The low-pressure cold plasma segment is projected to record the highest CAGR, primarily due to its increasing use in high-precision manufacturing processes, particularly in semiconductor fabrication, electronics component processing, and specialized medical applications. The segment benefits from the ability to operate under controlled vacuum conditions, enabling precise plasma density, treatment uniformity, and repeatable process outcomes. Rising investments in advanced manufacturing facilities and the increasing integration of plasma-based processes into automated production lines are expected to further accelerate the adoption of low-pressure systems. Europe accounted for the largest share of the cold plasma market by region. The global cold plasma market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe is expected to account for a significant share of the global cold plasma market, supported by the increasing adoption of cold plasma technologies across medical, polymer & plastic, textile, and electronics industries, as well as the strong presence of key market players in the region. The regional market is further supported by advanced manufacturing capabilities, stringent environmental regulations, growing demand for sustainable and chemical-free processing, and increasing investments in healthcare technologies. Moreover, the rising adoption of cold plasma for medical device sterilization, wound care, infection control, and industrial surface treatment, along with ongoing technological advancements and R&D activities, is expected to further drive market growth in Europe. A breakdown of the primary participants referred to for this report is provided below: ・By Company Type: Tier 1 (45%), Tier 2 (25%), and Tier 3 (30%) ・By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%) ・By Region: North America (35%), Europe (25%), Asia Pacific (20%), Latin America (15%), and the Middle East & Africa (5%) The major players operating in the cold plasma market are Apyx Medical (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i Ltd. (UK), Relyon Plasma GmbH (Germany), Henniker Plasma (UK), Enercon Industries Corporation (US), AcXys Plasma Technologies (France), Plasmatreat GmbH (Germany), Tantec A/S (Denmark), Europlasma NV (Belgium), Thierry Corp. (Germany), Surfx Technologies, LLC (US), SOFTAL Corona & Plasma GmbH (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), Terraplasma GmbH (Germany), Molecular Plasma Group SA (Germany), and CINOGY Technologies GmbH (Germany). Research Coverage This report studies the cold plasma market by industry, application, regime, and region. The report also examines factors such as drivers, restraints, opportunities, and challenges affecting market growth and provides details on the competitive landscape among market leaders. Furthermore, the report analyzes micromarkets by their individual growth trends and forecasts revenue for market segments across five major regions (and the countries within these regions). Reasons to Buy the Report The report will enable established firms, as well as entrants/smaller firms, to gauge the pulse of the market, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence. This report provides insights on the following pointers:  Analysis of key drivers (increased benefits and wider application, rising use in wound healing, growing applications in cancer and infectious disease, technological advancements, and rising demand for non-thermal sterilization and surface treatment), restraints (high capital investments and limited plasma penetration and non-uniform treatment), opportunities (sustainable and chemical-reduced processing and emerging countries offering opportunities), and challenges (limited commercialization and awareness and management of reactive species and process conditions)  Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global cold plasma market.  Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global cold plasma market  Market Development: Comprehensive information on the lucrative emerging markets by industry, application, and regime.  Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global cold plasma market.  Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global cold plasma market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 29
1.3.2 INCLUSIONS & EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 31
1.3.4 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 32
2 EXECUTIVE SUMMARY 33
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 33
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 34
2.3 DISRUPTIVE TRENDS IN COLD PLASMA MARKET 36
2.4 HIGH-GROWTH SEGMENTS 37
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 COLD PLASMA MARKET OVERVIEW 39
3.2 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY AND END USER 40
3.3 GEOGRAPHIC SNAPSHOT OF COLD PLASMA MARKET 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 42
4.2 MARKET DYNAMICS 42
4.2.1 DRIVERS 43
4.2.1.1 Growing preference for low-temperature and chemical-reduced processing to drive cold plasma adoption 43
4.2.1.2 Rising use of cold plasma in wound healing 43
4.2.1.3 Emerging applications in oncology and infectious diseases 44
4.2.1.4 Technological advancements and product innovation 45
4.2.1.5 Rising demand for non-thermal sterilization and surface treatment for medical devices 46
4.2.2 RESTRAINTS 46
4.2.2.1 High initial investments 46
4.2.2.2 Limited plasma penetration and non-uniform treatment 47
4.2.3 OPPORTUNITIES 47
4.2.3.1 Growing focus on sustainable and chemical-reduced processing 47
4.2.3.2 Favorable prospects in emerging economies 48
4.2.4 CHALLENGES 49
4.2.4.1 Limited commercialization and awareness 49
4.2.4.2 Management of reactive species and process conditions during cold plasma operations 49
4.3 UNMET NEEDS AND WHITE SPACES 50
4.3.1 UNMET NEEDS IN COLD PLASMA MARKET 50
4.3.2 WHITE SPACE OPPORTUNITIES 51
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 52
4.4.1 INTERCONNECTED MARKETS 52
4.4.2 CROSS-SECTOR OPPORTUNITIES 52
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 53
5 INDUSTRY TRENDS 54
5.1 PORTER’S FIVE FORCES ANALYSIS 54
5.1.1 THREAT OF NEW ENTRANTS 55
5.1.2 THREAT OF SUBSTITUTES 56
5.1.3 BARGAINING POWER OF BUYERS 56
5.1.4 BARGAINING POWER OF SUPPLIERS 56
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 56
5.2 MACROECONOMIC OUTLOOK 56
5.2.1 INTRODUCTION 56
5.2.2 GDP TRENDS & FORECAST 57
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRIES 58
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 59
5.3 SUPPLY CHAIN ANALYSIS 59
5.4 VALUE CHAIN ANALYSIS 61
5.5 ECOSYSTEM ANALYSIS 63
5.6 PRICING ANALYSIS 65
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2023–2025) 65
5.6.2 AVERAGE SELLING PRICE TREND, BY REGIME (2023–2025) 66
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025) 66
5.7 TRADE ANALYSIS 68
5.7.1 IMPORT SCENARIO (HS CODE 901890) 68
5.7.2 EXPORT SCENARIO (HS CODE 901890) 69
5.8 KEY CONFERENCES & EVENTS, 2026–2027 69
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.10 INVESTMENT & FUNDING SCENARIO 72
5.11 CASE STUDY ANALYSIS 73
5.11.1 CASE STUDY 1: COLD ATMOSPHERIC ARGON PLASMA FOR CHRONIC WOUND TREATMENT 73
5.11.2 CASE STUDY 2: PLASMA SURFACE ACTIVATION OF PEEK FOR MEDICAL DEVICES 74
5.11.3 CASE STUDY 3: PLASMA ACTIVATION FOR HIGH-QUALITY PAD PRINTING 74
5.12 IMPACT OF 2025 US TARIFFS—COLD PLASMA MARKET 75
5.12.1 INTRODUCTION 75
5.12.2 KEY TARIFF RATES 75
5.12.3 PRICE IMPACT ANALYSIS 76
5.12.4 IMPACT ON COUNTRIES/REGIONS 76
5.12.4.1 Canada 76
5.12.4.2 Asia Pacific 77
5.12.4.3 Europe 77
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 78
6.1 KEY EMERGING TECHNOLOGIES 78
6.1.1 DIELECTRIC BARRIER DISCHARGE (DBD) 78
6.1.2 ATMOSPHERIC PRESSURE PLASMA JET (APPJ) 78
6.1.3 PLASMA-ACTIVATED WATER/LIQUID (PAW/PAL) 79
6.2 COMPLEMENTARY TECHNOLOGIES 79
6.2.1 ULTRAVIOLET LIGHT 79
6.2.2 HYDROGEN PEROXIDE-BASED STERILIZATION 80
6.2.3 LASER TECHNOLOGY 80
6.3 ADJACENT TECHNOLOGIES 81
6.3.1 NANOTECHNOLOGY AND ANTIMICROBIAL COATINGS 81
6.3.2 ADVANCED SURFACE TREATMENT TECHNOLOGIES 82
6.4 TECHNOLOGY/PRODUCT ROADMAP 82
6.4.1 NEAR-TERM (2025–2027) INCLUDES ALL INDUSTRIES 82
6.4.2 MID-TERM (2028–2030) 83
6.4.3 LONG-TERM (2030+) 85
6.5 PATENT ANALYSIS 86
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS 87
6.6 FUTURE APPLICATIONS 89
6.6.1 PLASMA-ASSISTED PHARMACEUTICAL AND DRUG DELIVERY APPLICATIONS 90
6.6.2 ADVANCED AGRICULTURAL AND PLANT-PRODUCTION APPLICATIONS 90
6.6.3 FOOD WASTE VALORIZATION AND VALUE-ADDED FOOD PROCESSING 90
6.6.4 ADVANCED CONTAMINANT REMEDIATION IN WATER AND WASTEWATER 91
6.6.5 PLASMA-FUNCTIONALIZED BIOMATERIALS AND ADVANCED THERAPEUTIC MATERIALS 91
6.7 IMPACT OF AI/GENERATIVE AI ON COLD PLASMA MARKET 91
6.7.1 TOP USE CASES AND MARKET POTENTIAL 92
6.7.2 BEST PRACTICES 93
6.7.3 CASE STUDIES OF AI IMPLEMENTATION 93
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN COLD PLASMA MARKET 94
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 96
7.1 REGIONAL REGULATIONS & COMPLIANCE 96
7.1.1 NORTH AMERICA 96
7.1.2 EUROPE 96
7.1.3 ASIA PACIFIC 97
7.1.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
7.1.5 INDUSTRY STANDARDS 102
7.1.5.1 Medical Electrical Equipment Safety Standard – IEC 60601-1 102
7.1.5.2 Non-thermal Plasma Wound-treatment Equipment Standard – IEC 60601-2-91:2026 102
7.1.5.3 Quality Management System Standard For Medical Devices– ISO 13485:2016 102
7.1.5.4 Cold Atmospheric Pressure Plasma Characterization Specification – DIN SPEC 91315:2025-07 102
7.1.5.5 Environmental Management System Standard – ISO 14001:2026 102
7.1.5.6 Quality Management System Standard – ISO 9001:2015 103
7.2 SUSTAINABILITY INITIATIVES 103
7.2.1 SUSTAINABLE SURFACE TREATMENT THROUGH ATMOSPHERIC PLASMA – PLASMATREAT GMBH 103
7.2.2 REDUCING VOLATILE ORGANIC COMPOUND (VOCS) AND CHEMICAL USE THROUGH ATMOSPHERIC PLASMA – MYCRONIC 103
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 103
7.3.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 104
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 106
8.1 DECISION-MAKING PROCESS 106
8.1.1 DECISION-MAKING PROCESS 106
8.2 KEY STAKEHOLDERS & BUYING CRITERIA 109
8.2.1 BUYING CRITERIA 110
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 112
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 113
8.5 MARKET PROFITABILITY 114
9 COLD PLASMA MARKET, BY INDUSTRY 117
9.1 INTRODUCTION 118
9.2 POLYMER & PLASTIC INDUSTRY 119
9.2.1 GROWING ADOPTION OF ECO-FRIENDLY SURFACE MODIFICATION TECHNOLOGIES 119
9.3 TEXTILE INDUSTRY 121
9.3.1 COLD PLASMA TECHNOLOGY OFFERS COST-SAVING AND ECO-FRIENDLY OPTIONS FOR TEXTILE PROCESSING 121
9.4 ELECTRONICS & SEMICONDUCTOR INDUSTRY 123
9.4.1 GROWING SEMICONDUCTOR INDUSTRY DEMANDS SUPPORT ADOPTION OF ADVANCED PLASMA PROCESSING TECHNOLOGIES 123
9.5 FOOD & AGRICULTURE INDUSTRY 125
9.5.1 GROWING ADOPTION OF NON-THERMAL TECHNOLOGIES FOR FOOD PROCESSING AND AGRICULTURAL APPLICATIONS 125
9.6 MEDICAL INDUSTRY 127
9.6.1 GROWING CLINICAL ADOPTION OF COLD PLASMA FOR WOUND HEALING AND ANTIMICROBIAL APPLICATIONS 127
9.7 COSMETICS INDUSTRY 129
9.7.1 EXPANDING APPLICATION OF COLD PLASMA IN DERMATOLOGICAL AND AESTHETIC TREATMENTS 129
9.8 PHARMACEUTICAL INDUSTRY 131
9.8.1 EXPANDING APPLICATION OF COLD PLASMA IN PHARMACEUTICAL STERILIZATION AND DRUG DELIVERY 131
9.9 OTHER INDUSTRIES 133
10 COLD PLASMA MARKET, BY APPLICATION 135
10.1 INTRODUCTION 136
10.2 SURFACE TREATMENT & ACTIVATION 137
10.2.1 INCREASING DEMAND FOR IMPROVED SURFACE ADHESION AND ACTIVATION IN POLYMER PROCESSING 137
10.3 COATING & THIN-FILM DEPOSITION 139
10.3.1 INCREASING APPLICATION OF COLD PLASMA FOR FUNCTIONAL AND PROTECTIVE SURFACE COATINGS 139
10.4 PRINTING 140
10.4.1 BETTER DYE UPTAKE & PRINTING PERFORMANCE AND REDUCED RELIANCE ON WATER/CHEMICAL PRETREATMENT DRIVES ADOPTION 140
10.5 STERILIZATION & DECONTAMINATION 142
10.5.1 INCREASING APPLICATION OF COLD PLASMA FOR STERILIZATION & DECONTAMINATION DRIVES MARKET 142
10.6 WOUND HEALING 143
10.6.1 RISING PREVALENCE OF CHRONIC WOUNDS SUPPORTS USAGE OF COLD PLASMA IN WOUND MANAGEMENT 143
10.7 SURFACE ETCHING 145
10.7.1 INCREASING REQUIREMENT FOR HIGH-PRECISION PLASMA ETCHING IN SEMICONDUCTOR MANUFACTURING 145
10.8 SURGICAL APPLICATIONS 146
10.8.1 EXPANDING APPLICATIONS OF COLD PLASMA IN SURGICAL PROCEDURES AND CANCER TREATMENT 146
10.9 AESTHETIC SKIN PROCEDURES 148
10.9.1 INCREASING DEMAND FOR NON-SURGICAL AESTHETIC PROCEDURES SUPPORTS COLD PLASMA APPLICATIONS 148
10.10 OTHER APPLICATIONS 149
11 COLD PLASMA MARKET, BY REGIME 151
11.1 INTRODUCTION 152
11.2 ATMOSPHERIC COLD PLASMA 153
11.2.1 INCREASING ADOPTION OF ATMOSPHERIC COLD PLASMA FOR SCALABLE AND EFFICIENT SURFACE TREATMENT 153
11.3 LOW-PRESSURE COLD PLASMA 155
11.3.1 HIGH TREATMENT EFFECTIVENESS SUPPORTS APPLICATIONS DESPITE VACUUM-SYSTEM LIMITATIONS 155
12 COLD PLASMA MARKET, BY REGION 158
12.1 INTRODUCTION 159
12.2 NORTH AMERICA 159
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 160
12.2.2 US 163
12.2.2.1 Strong semiconductor investment, food-safety requirements, and medical applications support market growth 163
12.2.3 CANADA 166
12.2.3.1 Rising cancer cases & R&D to drive market growth in Canada 166
12.3 EUROPE 168
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 168
12.3.2 GERMANY 171
12.3.2.1 Strong industrial base and demand for sustainable processing technologies propel adoption 171
12.3.3 FRANCE 173
12.3.3.1 Strong electronics and semiconductor investments support cold plasma market growth 173
12.3.4 UK 175
12.3.4.1 Investments in semiconductor and agricultural technologies support cold plasma adoption 175
12.3.5 ITALY 177
12.3.5.1 Aging population and healthcare investment support cold plasma market growth 177
12.3.6 SPAIN 179
12.3.6.1 Growing healthcare needs and cancer burden support cold plasma applications in Spain 179
12.3.7 REST OF EUROPE 181
12.4 ASIA PACIFIC 183
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 183
12.4.2 CHINA 186
12.4.2.1 Strong textile, electronics, and food-processing industries support cold plasma adoption in China 186
12.4.3 JAPAN 189
12.4.3.1 Aging population, healthcare needs, and advanced manufacturing support cold plasma applications in Japan 189
12.4.4 INDIA 191
12.4.4.1 Growing R&D investment and textile exports support cold plasma adoption in India 191
12.4.5 AUSTRALIA 193
12.4.5.1 Growing healthcare needs and medical R&D support cold plasma adoption in Australia 193
12.4.6 SOUTH KOREA 195
12.4.6.1 Government support and advanced healthcare infrastructure support cold plasma adoption in South Korea 195
12.4.7 REST OF ASIA PACIFIC 197
12.5 LATIN AMERICA 199
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 199
12.5.2 BRAZIL 201
12.5.2.1 Growing R&D investment and healthcare innovation support cold plasma adoption in Brazil 201
12.5.3 MEXICO 203
12.5.3.1 Growing healthcare needs support cold plasma adoption in Mexico 203
12.5.4 REST OF LATIN AMERICA 205
12.6 MIDDLE EAST & AFRICA 207
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 207
12.6.2 GCC COUNTRIES 210
12.6.2.1 Kingdom of Saudi Arabia 212
12.6.2.1.1 Healthcare modernization and technology development drive cold plasma adoption in Saudi Arabia 212
12.6.2.2 UAE 214
12.6.2.2.1 Healthcare innovation and advanced technology development support cold plasma adoption in the UAE 214
12.6.2.3 Rest of GCC Countries 216
12.6.3 REST OF MIDDLE EAST & AFRICA 218
13 COMPETITIVE LANDSCAPE 220
13.1 INTRODUCTION 220
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026 220
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLD PLASMA MARKET 221
13.3 REVENUE ANALYSIS, 2023–2025 222
13.4 MARKET SHARE ANALYSIS, 2025 223
13.4.1 GLOBAL SHARE ANALYSIS FOR COLD PLASMA MARKET (2025) 223
13.4.2 US MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025) 225
13.4.3 EUROPE MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025) 226
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 228
13.5.1 STARS 228
13.5.2 EMERGING LEADERS 228
13.5.3 PERVASIVE PLAYERS 228
13.5.4 PARTICIPANTS 228
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 230
13.5.5.1 Company footprint 230
13.5.5.2 Region footprint 231
13.5.5.3 Industry footprint 232
13.5.5.4 Application footprint 233
13.5.5.5 Regime footprint 234
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 234
13.6.1 PROGRESSIVE COMPANIES 234
13.6.2 RESPONSIVE COMPANIES 234
13.6.3 DYNAMIC COMPANIES 235
13.6.4 STARTING BLOCKS 235
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 236
13.6.5.1 Detailed list of key startups/SMEs 236
13.6.5.2 Competitive benchmarking of key startups/SMEs 237
13.7 COMPANY VALUATION AND FINANCIAL METRICS 237
13.7.1 FINANCIAL METRICS 237
13.7.2 COMPANY VALUATION 238
13.8 BRAND/PRODUCT COMPARISON 239
13.9 COMPETITIVE SCENARIO 240
13.9.1 PRODUCT LAUNCHES & APPROVALS 240
13.9.2 DEALS 241
13.9.3 EXPANSIONS 242
13.9.4 OTHER DEVELOPMENTS 243
14 COMPANY PROFILES 244
14.1 KEY PLAYERS 244
14.1.1 NORDSON CORPORATION 244
14.1.1.1 Business overview 244
14.1.1.2 Products offered 245
14.1.1.3 Recent developments 247
14.1.1.3.1 Deals 247
14.1.1.3.2 Expansions 247
14.1.1.3.3 Other developments 248
14.1.1.4 MnM view 248
14.1.1.4.1 Right to win 248
14.1.1.4.2 Strategic choices 248
14.1.1.4.3 Weaknesses & competitive threats 249
14.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD. 250
14.1.2.1 Business overview 250
14.1.2.2 Products offered 251
14.1.2.3 Recent developments 252
14.1.2.3.1 Product launches 252
14.1.2.3.2 Deals 252
14.1.2.3.3 Expansions 253
14.1.2.3.4 Other developments 253
14.1.2.4 MnM view 254
14.1.2.4.1 Right to win 254
14.1.2.4.2 Strategic choices 254
14.1.2.4.3 Weaknesses and competitive threats 254
14.1.3 JUDGES SCIENTIFIC PLC 255
14.1.3.1 Business overview 255
14.1.3.2 Products offered 256
14.1.3.3 Recent developments 257
14.1.3.3.1 Product launches & updates 257
14.1.3.3.2 Deals 258
14.1.3.4 MnM view 258
14.1.3.4.1 Right to win 258
14.1.3.4.2 Strategic choices 259
14.1.3.4.3 Weaknesses and competitive threats 259
14.1.4 PVA TEPLA AG 260
14.1.4.1 Business overview 260
14.1.4.2 Products offered 261
14.1.4.3 MnM view 262
14.1.4.3.1 Right to win 262
14.1.4.3.2 Strategic choices 262
14.1.4.3.3 Weaknesses and competitive threats 263
14.1.5 BODYCOTE 264
14.1.5.1 Business overview 264
14.1.5.2 Products offered 265
14.1.5.3 Recent developments 266
14.1.5.3.1 Other developments 266
14.1.5.4 MnM view 266
14.1.5.4.1 Right to win 266
14.1.5.4.2 Strategic choices 266
14.1.5.4.3 Weaknesses and competitive threats 266
14.1.6 APYX MEDICAL CORPORATION 267
14.1.6.1 Business overview 267
14.1.6.2 Products offered 268
14.1.6.3 Recent developments 269
14.1.6.3.1 Product launches & approvals 269
14.1.6.3.2 Other developments 270
14.1.7 VIROMED MEDICAL AG 271
14.1.7.1 Business overview 271
14.1.7.2 Products offered 272
14.1.7.3 Recent developments 272
14.1.7.3.1 Product approvals 272
14.1.7.3.2 Deals 273
14.1.7.3.3 Other developments 274
14.1.8 SAMCO INC. 275
14.1.8.1 Business overview 275
14.1.8.2 Products offered 276
14.1.8.3 Recent developments 277
14.1.8.3.1 Product launches 277
14.1.9 MYCRONIC 278
14.1.9.1 Business overview 278
14.1.9.2 Products offered 279
14.1.9.3 Recent developments 280
14.1.9.3.1 Deals 280
14.1.9.3.2 Other developments 281
14.1.10 PLASMATREAT GMBH 282
14.1.10.1 Business overview 282
14.1.10.2 Products offered 282
14.1.10.3 Recent developments 284
14.1.10.3.1 Product launches 284
14.1.10.3.2 Deals 285
14.1.10.3.3 Expansions 286
14.1.10.3.4 Other developments 286
14.1.11 P2I LTD 288
14.1.11.1 Business overview 288
14.1.11.2 Products offered 288
14.1.11.3 Recent developments 289
14.1.11.3.1 Deals 289
14.1.11.3.2 Other developments 289
14.1.12 ENERCON INDUSTRIES CORPORATION 290
14.1.12.1 Business overview 290
14.1.12.2 Products offered 290
14.1.12.3 Recent developments 291
14.1.12.3.1 Product launches 291
14.1.12.3.2 Expansions 291
14.1.13 TANTEC A/S 292
14.1.13.1 Business overview 292
14.1.13.2 Products offered 292
14.1.13.3 Recent developments 293
14.1.13.3.1 Product launches 293
14.1.13.3.2 Deals 293
14.1.14 ACXYS TECHNOLOGIES 294
14.1.14.1 Business overview 294
14.1.14.2 Products offered 294
14.1.14.3 Recent developments 295
14.1.14.3.1 Product launches 295
14.1.15 KEYLINK 296
14.1.15.1 Business overview 296
14.1.15.2 Products offered 296
14.1.15.3 Recent developments 297
14.1.15.3.1 Other developments 297
14.2 OTHER PLAYERS 299
14.2.1 DIENER ELECTRONIC GMBH & CO.KG 299
14.2.2 US MEDICAL INNOVATIONS 300
14.2.3 LEAFLIFE TECHNOLOGY 301
14.2.4 SOFTAL CORONA & PLASMA GMBH 301
14.2.5 FERRARINI & BENELLI SRL 302
14.2.6 NEOPLAS MED GMBH 303
14.2.7 TERRAPLASMA GMBH 304
14.2.8 MOLECULAR PLASMA GROUP 305
14.2.9 CINOGY TECHNOLOGIES GMBH 306
14.2.10 PLASMALEX 307
15 RESEARCH METHODOLOGY 308
15.1 RESEARCH DATA 308
15.1.1 SECONDARY DATA 309
15.1.1.1 Key data from secondary sources 310
15.1.2 PRIMARY DATA 311
15.1.2.1 Key data from primary sources 312
15.1.2.2 Key industry insights 313
15.1.2.3 Breakdown of primary interviews 313
15.1.2.4 Key industry insights 314
15.2 MARKET SIZE ESTIMATION 315
15.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 316
15.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 318
15.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS 319
15.2.4 TOP-DOWN APPROACH 319
15.2.5 BASE NUMBER CALCULATION 320
15.2.6 DEMAND-SIDE APPROACH 321
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION 325
15.4 MARKET SHARE ASSESSMENT 326
15.5 RESEARCH ASSUMPTIONS 326
15.5.1 STUDY ASSUMPTIONS 326
15.5.2 GROWTH RATE ASSUMPTIONS 327
15.6 RISK ASSESSMENT 327
15.7 RESEARCH LIMITATIONS 327
16 APPENDIX 328
16.1 DISCUSSION GUIDE 328
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 332
16.3 CUSTOMIZATION OPTIONS 334
16.3.1 PRODUCT ANALYSIS 334
16.3.2 GEOGRAPHIC ANALYSIS 334
16.4 RELATED REPORTS 334
16.5 AUTHOR DETAILS 335

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 MARKET SCENARIO 33.
FIGURE 2 GLOBAL COLD PLASMA MARKET, 2024–2031 34.
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS COLD PLASMA MARKET, 2024–2026 34.
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF COLD PLASMA MARKET 36.
FIGURE 5 HIGH-GROWTH SEGMENTS IN COLD PLASMA MARKET, 2026–2031 37.
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN COLD PLASMA MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 38.
FIGURE 7 INCREASING USE OF COLD PLASMA FOR STERILIZATION, SURFACE TREATMENT, AND DECONTAMINATION TO DRIVE MARKET GROWTH 39.
FIGURE 8 POLYMER & PLASTICS INDUSTRY ACCOUNTED FOR LARGEST SHARE IN 2025 40.
FIGURE 9 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 41.
FIGURE 10 COLD PLASMA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42.
FIGURE 11 COLD PLASMA MARKET: PORTER'S FIVE FORCES ANALYSIS 55.
FIGURE 12 SUPPLY CHAIN ANALYSIS 61.
FIGURE 13 COLD PLASMA PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS 63.
FIGURE 14 COLD PLASMA MARKET: ECOSYSTEM ANALYSIS 64.
FIGURE 15 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY REGIME, 2023–2025 (USD) 66.
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN COLD PLASMA MARKET 71.
FIGURE 17 INVESTMENT & FUNDING SCENARIO (2023–2026) 73.
FIGURE 18 COLD PLASMA MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016–JULY 2026) 86.
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR COLD PLASMA GENERATORS (JANUARY 2016–JULY 2026) 88.
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN COLD PLASMA MARKET 92.
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY 109.
FIGURE 22 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY 111.
FIGURE 23 NORTH AMERICA: COLD PLASMA MARKET SNAPSHOT (2025) 161.
FIGURE 24 ASIA PACIFIC: COLD PLASMA MARKET SNAPSHOT (2025) 184.
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN COLD PLASMA MARKET, 2023–2025 222.
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 223.
FIGURE 27 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 226.
FIGURE 28 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 227.
FIGURE 29 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 229.
FIGURE 30 COLD PLASMA MARKET: COMPANY FOOTPRINT 230.
FIGURE 31 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 235.
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR COLD PLASMA MARKET 237.
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR COLD PLASMA MARKET 238.
FIGURE 34 COLD PLASMA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 239.
FIGURE 35 NORDSON CORPORATION: COMPANY SNAPSHOT (2025) 245.
FIGURE 36 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2025) 251.
FIGURE 37 JUDGES SCIENTIFIC PLC: COMPANY SNAPSHOT (2025) 256.
FIGURE 38 PVA TEPLA AG: COMPANY SNAPSHOT (2025) 261.
FIGURE 39 BODYCOTE: COMPANY SNAPSHOT (2025) 265.
FIGURE 40 APYX MEDICAL CORPORATION: COMPANY SNAPSHOT (2025) 268.
FIGURE 41 VIROMED MEDICAL AG: COMPANY SNAPSHOT (2025) 271.
FIGURE 42 SAMCO INC.: COMPANY SNAPSHOT (2025) 276.
FIGURE 43 MYCRONIC: COMPANY SNAPSHOT (2025) 279.
FIGURE 44 COLD PLASMA MARKET: RESEARCH DESIGN 308.
FIGURE 45 PRIMARY SOURCES 311.
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 313.
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 314.
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 314.
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 316.
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 317.
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: NORDSON CORPORATION (2025) 318.
FIGURE 52 BOTTOM-UP APPROACH 319.
FIGURE 53 TOP-DOWN APPROACH 319.
FIGURE 54 SUPPLY-SIDE ANALYSIS: COLD PLASMA MARKET (2025) 320.
FIGURE 55 DEMAND-SIDE APPROACH 322.
FIGURE 56 COLD PLASMA MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 323.
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 324.
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY 325.
TABLE 1 COLD PLASMA MARKET: INCLUSIONS & EXCLUSIONS 30.
TABLE 2 STANDARD CURRENCY CONVERSION RATES 31.
TABLE 3 WHITE SPACE OPPORTUNITIES IN COLD PLASMA MARKET 51.
TABLE 4 INTERCONNECTED MARKETS IN COLD PLASMA MARKET 52.
TABLE 5 CROSS-SECTOR OPPORTUNITIES IN COLD PLASMA MARKET 52.
TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN COLD PLASMA MARKET 53.
TABLE 7 COLD PLASMA MARKET: PORTER’S FIVE FORCES ANALYSIS 54.
TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION) 57.
TABLE 9 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 65.
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION (2023−2025) (USD) 67.
TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021–2025 (USD THOUSANDS) 68.
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021–2025 (USD THOUSANDS) 69.
TABLE 13 COLD PLASMA MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027 69.
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES,2025 75.
TABLE 15 COLD PLASMA MARKET: MAJOR PATENTS 88.
TABLE 16 KEY COMPANIES IMPLEMENTING AI IN COLD PLASMA MARKET 92.
TABLE 17 BEST PRACTICES IN COLD PLASMA MARKET 93.
TABLE 18 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN THE COLD PLASMA MARKET 93.
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94.
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98.
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99.
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100.
TABLE 23 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101.
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY 110.
TABLE 25 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY 112.
TABLE 26 ADOPTION BARRIERS AND INTERNAL CHALLENGES IN THE COLD PLASMA MARKET 112.
TABLE 27 UNMET NEEDS IN COLD PLASMA MARKET FROM VARIOUS END USERS 113.
TABLE 28 COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 118.
TABLE 29 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118.
TABLE 30 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE POLYMER & PLASTIC INDUSTRY 120.
TABLE 31 COLD PLASMA MARKET FOR THE POLYMER & PLASTIC INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 120.
TABLE 32 COMPARISON BETWEEN PLASMA TREATMENT AND TRADITIONAL TEXTILE PROCESSING 121.
TABLE 33 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE TEXTILE INDUSTRY 121.
TABLE 34 COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 35 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE ELECTRONICS & SEMICONDUCTOR INDUSTRY 123.
TABLE 36 COLD PLASMA MARKET FOR ELECTRONICS & SEMICONDUCTOR INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 37 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE FOOD & AGRICULTURE INDUSTRY 125.
TABLE 38 COLD PLASMA MARKET FOR THE FOOD & AGRICULTURE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 39 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE MEDICAL INDUSTRY 127.
TABLE 40 COLD PLASMA MARKET FOR THE MEDICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 128.
TABLE 41 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE COSMETICS INDUSTRY 129.
TABLE 42 COLD PLASMA MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 130.
TABLE 43 KEY PLAYERS PROVIDING PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY 131.
TABLE 44 COLD PLASMA MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 132.
TABLE 45 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR OTHER INDUSTRIES 133.
TABLE 46 COLD PLASMA MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 47 COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 136.
TABLE 48 COLD PLASMA MARKET FOR APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 137.
TABLE 49 COLD PLASMA MARKET FOR SURFACE TREATMENT & ACTIVATION, BY COUNTRY, 2024–2031 (USD MILLION) 138.
TABLE 50 COLD PLASMA MARKET FOR COATING & THIN-FILM DEPOSITION, BY COUNTRY, 2024–2031 (USD MILLION) 139.
TABLE 51 COLD PLASMA MARKET FOR PRINTING, BY COUNTRY, 2024–2031 (USD MILLION) 141.
TABLE 52 COLD PLASMA MARKET FOR STERILIZATION & DECONTAMINATION, BY COUNTRY, 2024–2031 (USD MILLION) 142.
TABLE 53 COLD PLASMA MARKET FOR WOUND HEALING, BY COUNTRY, 2024–2031 (USD MILLION) 144.
TABLE 54 COLD PLASMA MARKET FOR SURFACE ETCHING, BY COUNTRY, 2024–2031 (USD MILLION) 145.
TABLE 55 COLD PLASMA MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 147.
TABLE 56 COLD PLASMA MARKET FOR AESTHETIC SKIN PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 148.
TABLE 57 COLD PLASMA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 150.
TABLE 58 COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 152.
TABLE 59 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152.
TABLE 60 ATMOSPHERIC COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS) 154.
TABLE 61 ATMOSPHERIC COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154.
TABLE 62 LOW PRESSURE COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS) 156.
TABLE 63 LOW-PRESSURE COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156.
TABLE 64 COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION) 159.
TABLE 65 NORTH AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161.
TABLE 66 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 162.
TABLE 67 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 162.
TABLE 68 NORTH AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 162.
TABLE 69 NORTH AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 163.
TABLE 70 US: MACROECONOMIC INDICATORS 164.
TABLE 71 US: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 164.
TABLE 72 US: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 165.
TABLE 73 US: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165.
TABLE 74 CANADA: MACROECONOMIC INDICATORS 166.
TABLE 75 CANADA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 166.
TABLE 76 CANADA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 167.
TABLE 77 CANADA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 167.
TABLE 78 EUROPE: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169.
TABLE 79 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 169.
TABLE 80 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 169.
TABLE 81 EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 170.
TABLE 82 EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 170.
TABLE 83 GERMANY: MACROECONOMIC INDICATORS 171.
TABLE 84 GERMANY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 172.
TABLE 85 GERMANY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 172.
TABLE 86 GERMANY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 173.
TABLE 87 FRANCE: MACROECONOMIC INDICATORS 174.
TABLE 88 FRANCE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 174.
TABLE 89 FRANCE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 174.
TABLE 90 FRANCE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175.
TABLE 91 UK: MACROECONOMIC INDICATORS 176.
TABLE 92 UK: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 176.
TABLE 93 UK: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 176.
TABLE 94 UK: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 177.
TABLE 95 ITALY: MACROECONOMIC INDICATORS 178.
TABLE 96 ITALY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 178.
TABLE 97 ITALY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 178.
TABLE 98 ITALY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 179.
TABLE 99 SPAIN: MACROECONOMIC INDICATORS 179.
TABLE 100 SPAIN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 180.
TABLE 101 SPAIN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 180.
TABLE 102 SPAIN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 181.
TABLE 103 REST OF EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 181.
TABLE 104 REST OF EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 182.
TABLE 105 REST OF EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 182.
TABLE 106 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184.
TABLE 107 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 185.
TABLE 108 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 185.
TABLE 109 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 185.
TABLE 110 ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 186.
TABLE 111 CHINA: MACROECONOMIC INDICATORS 187.
TABLE 112 CHINA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 187.
TABLE 113 CHINA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 188.
TABLE 114 CHINA: COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY APPLICATION, 2024–2031 (USD MILLION) 188.
TABLE 115 JAPAN: MACROECONOMIC INDICATORS 189.
TABLE 116 JAPAN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 189.
TABLE 117 JAPAN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 190.
TABLE 118 JAPAN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190.
TABLE 119 INDIA: MACROECONOMIC INDICATORS 191.
TABLE 120 INDIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 191.
TABLE 121 INDIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 192.
TABLE 122 INDIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 192.
TABLE 123 AUSTRALIA: MACROECONOMIC INDICATORS 193.
TABLE 124 AUSTRALIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 193.
TABLE 125 AUSTRALIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 194.
TABLE 126 AUSTRALIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 194.
TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS 195.
TABLE 128 SOUTH KOREA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 195.
TABLE 129 SOUTH KOREA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 196.
TABLE 130 SOUTH KOREA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 196.
TABLE 131 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 197.
TABLE 132 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 198.
TABLE 133 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 198.
TABLE 134 LATIN AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199.
TABLE 135 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 200.
TABLE 136 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 200.
TABLE 137 LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 200.
TABLE 138 LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 201.
TABLE 139 BRAZIL: MACROECONOMIC INDICATORS 202.
TABLE 140 BRAZIL: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 202.
TABLE 141 BRAZIL: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 202.
TABLE 142 BRAZIL: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 203.
TABLE 143 MEXICO: MACROECONOMIC INDICATORS 203.
TABLE 144 MEXICO: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 204.
TABLE 145 MEXICO: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 204.
TABLE 146 MEXICO: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205.
TABLE 147 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 206.
TABLE 148 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 206.
TABLE 149 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 207.
TABLE 150 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION) 208.
TABLE 151 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 208.
TABLE 152 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 209.
TABLE 153 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 209.
TABLE 154 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 210.
TABLE 155 GCC COUNTRIES: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211.
TABLE 156 GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 211.
TABLE 157 GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 211.
TABLE 158 GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 212.
TABLE 159 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS 212.
TABLE 160 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 213.
TABLE 161 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 213.
TABLE 162 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 214.
TABLE 163 UAE: MACROECONOMIC INDICATORS 215.
TABLE 164 UAE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 215.
TABLE 165 UAE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 215.
TABLE 166 UAE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 216.
TABLE 167 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 216.
TABLE 168 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 217.
TABLE 169 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 217.
TABLE 170 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 218.
TABLE 171 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 218.
TABLE 172 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219.
TABLE 173 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, JANUARY 2023–JULY 2026 221.
TABLE 174 COLD PLASMA MARKET: DEGREE OF COMPETITION 224.
TABLE 175 US COLD PLASMA MARKET: DEGREE OF COMPETITION 226.
TABLE 176 EUROPE COLD PLASMA MARKET: DEGREE OF COMPETITION 227.
TABLE 177 COLD PLASMA MARKET: REGION FOOTPRINT 231.
TABLE 178 COLD PLASMA MARKET: INDUSTRY FOOTPRINT 232.
TABLE 179 COLD PLASMA MARKET: APPLICATION FOOTPRINT 233.
TABLE 180 COLD PLASMA MARKET: REGIME FOOTPRINT 234.
TABLE 181 COLD PLASMA MARKET: DETAILED LIST OF KEY STARTUPS/SMES 236.
TABLE 182 COLD PLASMA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS 237.
TABLE 183 COLD PLASMA MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 240.
TABLE 184 COLD PLASMA MARKET: DEALS, JANUARY 2023–JULY 2026 241.
TABLE 185 COLD PLASMA MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 242.
TABLE 186 COLD PLASMA MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 243.
TABLE 187 NORDSON CORPORATION: COMPANY OVERVIEW 244.
TABLE 188 NORDSON CORPORATION: PRODUCTS OFFERED 245.
TABLE 189 NORDSON CORPORATION: DEALS, JANUARY 2023–JULY 2026 247.
TABLE 190 NORDSON CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 247.
TABLE 191 NORDSON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 248.
TABLE 192 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 250.
TABLE 193 ADTEC PLASMA TECHNOLOGY CO., LTD: PRODUCTS OFFERED 251.
TABLE 194 ADTEC PLASMA TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 252.
TABLE 195 ADTEC PLASMA TECHNOLOGY CO., LTD.: DEALS, JANUARY 2023–JULY 2026 252.
TABLE 196 ADTEC PLASMA TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026 253.
TABLE 197 ADTEC PLASMA TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 253.
TABLE 198 JUDGES SCIENTIFIC PLC: COMPANY OVERVIEW 255.
TABLE 199 JUDGES SCIENTIFIC PLC: PRODUCTS OFFERED 256.
TABLE 200 JUDGES SCIENTIFIC PLC: PRODUCT LAUNCHES & UPDATES, JANUARY 2023–JULY 2026 257.
TABLE 201 JUDGES SCIENTIFIC PLC: DEALS, JANUARY 2023- JULY 2026 258.
TABLE 202 PVA TEPLA AG: COMPANY OVERVIEW 260.
TABLE 203 PVA TEPLA AG: PRODUCTS OFFERED 261.
TABLE 204 BODYCOTE.: COMPANY OVERVIEW 264.
TABLE 205 BODYCOTE: PRODUCTS OFFERED 265.
TABLE 206 BODYCOTE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 266.
TABLE 207 APYX MEDICAL CORPORATION: COMPANY OVERVIEW 267.
TABLE 208 APYX MEDICAL CORPORATION: PRODUCTS OFFERED 268.
TABLE 209 APYX MEDICAL CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 269.
TABLE 210 APYX MEDICAL CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 270.
TABLE 211 VIROMED MEDICAL AG: COMPANY OVERVIEW 271.
TABLE 212 VIROMED MEDICAL AG: PRODUCTS OFFERED 272.
TABLE 213 VIROMED MEDICAL AG: PRODUCT APPROVALS, JANUARY 2023–JULY 2026 272.
TABLE 214 VIROMED MEDICAL AG: DEALS, JANUARY 2023- JULY 2026 273.
TABLE 215 VIROMED MEDICAL AG: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 274.
TABLE 216 SAMCO INC.: COMPANY OVERVIEW 275.
TABLE 217 SAMCO INC.: PRODUCTS OFFERED 276.
TABLE 218 SAMCO INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 277.
TABLE 219 MYCRONIC: COMPANY OVERVIEW 278.
TABLE 220 MYCRONIC: PRODUCTS OFFERED 279.
TABLE 221 MYCRONIC: DEALS, JANUARY 2023- JULY 2026 280.
TABLE 222 MYCRONIC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 281.
TABLE 223 PLASMATREAT GMBH: COMPANY OVERVIEW 282.
TABLE 224 PLASMATREAT GMBH: PRODUCTS OFFERED 282.
TABLE 225 PLASMATREAT GMBH: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 284.
TABLE 226 PLASMATREAT GMBH: DEALS, JANUARY 2023- JULY 2026 285.
TABLE 227 PLASMATREAT GMBH: EXPANSIONS, JANUARY 2023–JULY 2026 286.
TABLE 228 PLASMATREAT GMBH: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 286.
TABLE 229 P2I LTD: COMPANY OVERVIEW 288.
TABLE 230 P2I LTD: PRODUCTS OFFERED 288.
TABLE 231 P2I LTD: DEALS, JANUARY 2023- JULY 2026 289.
TABLE 232 P2I LTD: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 289.
TABLE 233 ENERCON INDUSTRIES CORPORATION: COMPANY OVERVIEW 290.
TABLE 234 ENERCON INDUSTRIES CORPORATION: PRODUCTS OFFERED 290.
TABLE 235 ENERCON INDUSTRIES CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026 291.
TABLE 236 ENERCON INDUSTRIES CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 291.
TABLE 237 TANTEC A/S: COMPANY OVERVIEW 292.
TABLE 238 TANTEC A/S: PRODUCTS OFFERED 292.
TABLE 239 TANTEC A/S: SERVICE LAUNCHES, JANUARY 2023- JULY 2026 293.
TABLE 240 TANTEC A/S: DEALS, JANUARY 2023- JULY 2026 293.
TABLE 241 ACXYS TECHNOLOGIES.: COMPANY OVERVIEW 294.
TABLE 242 ACXYS TECHNOLOGIES: PRODUCTS OFFERED 294.
TABLE 243 ACXYS TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2023- JULY 2026 295.
TABLE 244 KEYLINK: COMPANY OVERVIEW 296.
TABLE 245 KEYLINK: PRODUCTS OFFERED 296.
TABLE 246 KEYLINK: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 297.
TABLE 247 STUDY ASSUMPTIONS 326.
TABLE 248 COLD PLASMA MARKET: RISK ASSESSMENT ANALYSIS 327.